Nuveen Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$15.7M Buy
795,612
+54,361
+7% +$1.08M ﹤0.01% 1317
2024
Q3
$18.5M Sell
741,251
-25,160
-3% -$629K 0.01% 1246
2024
Q2
$14.3M Sell
766,411
-64,688
-8% -$1.21M ﹤0.01% 1350
2024
Q1
$16.4M Buy
831,099
+420,075
+102% +$8.29M ﹤0.01% 1302
2023
Q4
$7.21M Sell
411,024
-152,902
-27% -$2.68M ﹤0.01% 1776
2023
Q3
$9.8M Buy
563,926
+450,181
+396% +$7.82M ﹤0.01% 1498
2023
Q2
$1.6M Hold
113,745
﹤0.01% 2447
2023
Q1
$1.22M Sell
113,745
-40,573
-26% -$437K ﹤0.01% 2536
2022
Q4
$2.31M Buy
154,318
+50,931
+49% +$763K ﹤0.01% 2321
2022
Q3
$1.33M Sell
103,387
-4,767
-4% -$61.2K ﹤0.01% 2608
2022
Q2
$1.05M Buy
108,154
+14,176
+15% +$137K ﹤0.01% 2757
2022
Q1
$966K Sell
93,978
-13,331
-12% -$137K ﹤0.01% 2826
2021
Q4
$1.26M Buy
107,309
+4,493
+4% +$52.9K ﹤0.01% 2771
2021
Q3
$1.25M Sell
102,816
-670
-0.6% -$8.17K ﹤0.01% 2899
2021
Q2
$1.44M Buy
103,486
+11,543
+13% +$161K ﹤0.01% 2858
2021
Q1
$1.7M Sell
91,943
-337,060
-79% -$6.24M ﹤0.01% 2691
2020
Q4
$7.58M Sell
429,003
-15,626
-4% -$276K ﹤0.01% 1870
2020
Q3
$6.81M Buy
444,629
+115,527
+35% +$1.77M ﹤0.01% 1751
2020
Q2
$8.39M Buy
329,102
+62,915
+24% +$1.6M ﹤0.01% 1602
2020
Q1
$4.12M Buy
266,187
+229,217
+620% +$3.55M ﹤0.01% 1828
2019
Q4
$409K Sell
36,970
-3,770
-9% -$41.7K ﹤0.01% 2949
2019
Q3
$347K Buy
40,740
+2,251
+6% +$19.2K ﹤0.01% 3029
2019
Q2
$521K Buy
+38,489
New +$521K ﹤0.01% 2985